What can I claim secondary to polyarteritis nodosa?
3 conditions in the Repatriation Medical Authority's Statements of Principles list polyarteritis nodosa as a factor. If DVA has accepted your polyarteritis nodosa, each of these has a documented pathway to a further claim.
At a glance
- Accepted conditionPolyarteritis nodosa
- Conditions it may open3
- SourceRMA SoPs
- Chart Review$600 + GST
How a secondary claim works
Some Statement of Principles factors are not about service at all — they name another condition. Where DVA has already accepted your polyarteritis nodosa, and another condition's SoP lists polyarteritis nodosa as a factor, that part of the next claim is already established on your file. How a secondary claim works, in full →
Conditions that list polyarteritis nodosa as a factor
Quoted from the instrument. A pathway existing is not the same as a claim succeeding — each factor carries thresholds your record has to satisfy.
Myocarditis
RH No. 17 of 2024 · BoP No. 18 of 2024
Reasonable Hypothesis — factor (7): “having one of the following vasculitides: (a) Behcet disease; (b) eosinophilic granulomatosis with polyangiitis (Churg Strauss syndrome); (c) giant cell (temporal) arteritis; (d) granulomatosis with polyangiitis (Wegener granulomatosis); (e) Kawasaki disease; (f) polyarteritis nodosa; or (g) Takayasu arteritis; at the time of clinical onset or clinical worsening” [onset and worsening]
Balance of Probabilities — factor (7): “having one of the following vasculitides: Behcet disease; eosinophilic granulomatosis with polyangiitis (Churg Strauss syndrome); giant cell (temporal) arteritis; granulomatosis with polyangiitis (Wegener granulomatosis); Kawasaki disease; polyarteritis nodosa; or Takayasu arteritis; at the time of clinical onset or clinical worsening” [onset and worsening]
Pericarditis
RH No. 90 of 2023 · BoP No. 91 of 2023
Reasonable Hypothesis — factor (15): “having one of the following vasculitides: (a) Behcet's disease; (b) eosinophilic granulomatosis with polyangiitis (Churg Straus syndrome); (c) giant cell (temporal) arteritis; (d) granulomatosis with polyangiitis (Wegener's granulomatosis); (e) microscopic polyangiitis; (f) polyarteritis nodosa; or (g) Takayasu's arteritis; at the time of the clinical onset or clinical worsening of pericarditis” [onset and worsening]
Balance of Probabilities — factor (15): “having one of the following vasculitides: (a) Behcet's disease; (b) eosinophilic granulomatosis with polyangiitis (Churg Straus syndrome); (c) giant cell (temporal) arteritis; (d) granulomatosis with polyangiitis (Wegener's granulomatosis); (e) microscopic polyangiitis; (f) polyarteritis nodosa; or (g) Takayasu's arteritis; at the time of the clinical onset or clinical worsening of pericarditis” [onset and worsening]
Trigeminal neuralgia or trigeminal neuropathy
RH No. 84 of 2024 · BoP No. 85 of 2024
Reasonable Hypothesis — factor (13): “having one of the following systemic vasculitides: (a) Behçet disease; (b) eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome); (c) giant cell arteritis; (d) granulomatosis with polyangiitis (Wegener granulomatosis); (e) polyarteritis nodosa; (f) Takayasu arteritis; at the time of clinical onset or clinical worsening of trigeminal neuropathy” [onset and worsening]
This factor appears in the Reasonable Hypothesis instrument only, which applies to operational service.
Other accepted conditions that also open myocarditis
If any of these is also on your file, it reaches some of the same conditions polyarteritis nodosa does.
What DVA means by polyarteritis nodosa
A claim is tested against the definition first. If the diagnosis on your file does not meet this wording, the factors below never get reached — so it is worth checking that what your doctor wrote matches what the instrument requires.
Polyarteritis nodosa, for the purposes of the Statement of Principles, for the purposes of this Statement of Principles, polyarteritis nodosa: (a) means a non-granulomatous necrotising arteritis predominantly affecting medium or small arteries; and (b) includes cutaneous polyarteritis nodosa and single organ polyarteritis nodosa; and (c) excludes: (i) glomerulonephritis; (ii) Kawasaki disease; (iii) microscopic polyangiitis; and (iv) polyangiitis overlap syndrome.
Aggravation-only factors. In this instrument, subsections 9(7) to 9(11) apply only to material contribution to, or aggravation of, polyarteritis nodosa where it was already present before or during service. If service caused polyarteritis nodosa outright, those factors are not available to you.
RH No. 33 of 2020 · BoP No. 34 of 2020 · 5 factors
What could support a claim for polyarteritis nodosa?
The Statement of Principles for polyarteritis nodosa names 2 other conditions among its own factors. If any of these is already accepted on your file, it may be the factor that carries a polyarteritis nodosa claim — quoted here from the instrument.
Hepatitis B
Reasonable Hypothesis — factor (1): “having infection with hepatitis B virus at the time of the clinical onset of polyarteritis nodosa” [clinical onset]
Reasonable Hypothesis — factor (6): “having had a hepatitis B vaccination within the three months before the clinical onset of polyarteritis nodosa” [clinical onset]
Hepatitis C
Reasonable Hypothesis — factor (2): “having infection with hepatitis C virus at the time of the clinical onset of polyarteritis nodosa” [clinical onset]
Reasonable Hypothesis — factor (8): “having infection with hepatitis C virus at the time of the clinical worsening of polyarteritis nodosa” [worsening]
Reviewed by Dr Thomas Perkins
Founding doctor, Veterans Health Centre · former RAAF aviation medical officer · 13 years working exclusively with ADF members and veterans. Full profile →
Polyarteritis nodosa accepted?
Contact us for more information.